Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent

N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent

US Patent 6214851 · Granted Apr 10, 2001

Estimated economic value: $174,675,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocyclic PAD4 inhibitors useful as immunosuppressant2025
Macrocyclic PAD4 inhibitors useful as immunosuppressant2025
Heterocyclic PAD4 inhibitors2025
Heterocyclic PAD4 inhibitors2025
Substituted thienopyrroles as PAD4 inhibitors2024
Substituted thienopyrroles as PAD4 inhibitors2024
Heteroaryl substituted aminopyridine compounds2020
Heteroaryl substituted aminopyridine compounds2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators2020
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alph2019
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alph2019